Pak1 as a Novel Therapeutic Target for Antihypertrophic Treatment in the Heart
- 13 December 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 124 (24) , 2702-2715
Abstract
Background—: Stress-induced hypertrophic remodeling is a critical pathogenetic process leading to heart failure. Although many signal transduction cascades are demonstrated as important regulators to facilitate the induction of cardiac hypertrophy, the signaling pathways for suppressing hypertrophic remodeling remain largely unexplored. In this study, we identified p21-activated kinase 1 (Pak1) as a novel signaling regulator that antagonizes cardiac hypertrophy. Methods and Results—: Hypertrophic stress applied to primary neonatal rat cardiomyocytes (NRCMs) or murine hearts caused the activation of Pak1. Analysis of NRCMs expressing constitutively active Pak1 or in which Pak1 was silenced disclosed that Pak1 played an antihypertrophic role. To investigate the in vivo role of Pak1 in the heart, we generated mice with a cardiomyocyte-specific deletion of Pak1 (Pak1 cko ). When subjected to 2 weeks of pressure overload, Pak1 cko mice developed greater cardiac hypertrophy with attendant blunting of JNK activation compared with controls, and these knockout mice underwent the transition into heart failure when prolonged stress was applied. Chronic angiotensin II infusion also caused increased cardiac hypertrophy in Pak1 cko mice. Moreover, we discovered that the Pak1 activator FTY720, a sphingosine-like analog, was able to prevent pressure overload-induced hypertrophy in wild-type mice without compromising their cardiac functions. Meanwhile, FTY720 failed to exert such an effect on Pak1 cko mice, suggesting that the antihypertrophic effect of FTY720 likely acts through Pak1 activation. Conclusions—: These results, for the first time, establish Pak1 as a novel antihypertrophic regulator and suggest that it may be a potential therapeutic target for the treatment of cardiac hypertrophy and heart failure.Keywords
This publication has 48 references indexed in Scilit:
- Targeted Deletion of the Extracellular Signal-Regulated Protein Kinase 5 Attenuates Hypertrophic Response and Promotes Pressure Overload–Induced Apoptosis in the HeartCirculation Research, 2010
- FTY720 prevents ischemia/reperfusion injury-associated arrhythmias in an ex vivo rat heart model via activation of Pak1/Akt signalingJournal of Molecular and Cellular Cardiology, 2010
- Cdc42 is an antihypertrophic molecular switch in the mouse heartJournal of Clinical Investigation, 2009
- Pak protein kinases and their role in cancerCancer and Metastasis Reviews, 2009
- Regulation of Akt/PKB activity by P21-activated kinase in cardiomyocytesJournal of Molecular and Cellular Cardiology, 2008
- Targeted Deletion of the Mitogen-Activated Protein Kinase Kinase 4 Gene in the Nervous System Causes Severe Brain Developmental Defects and Premature DeathMolecular and Cellular Biology, 2007
- Regulation of L-Type Calcium Channel and Delayed Rectifier Potassium Channel Activity by p 21 -Activated Kinase-1 in Guinea Pig Sinoatrial Node Pacemaker CellsCirculation Research, 2007
- Requirement of Rac1 in the development of cardiac hypertrophyProceedings of the National Academy of Sciences, 2006
- Intracellular Localization and Functional Effects of P 21 -Activated Kinase-1 (Pak1) in Cardiac MyocytesCirculation Research, 2004
- Cdc42‐independent activation and translocation of the cytostatic p21‐activated protein kinase γ‐PAK by sphingosineFEBS Letters, 2001